Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
engineered bacterial strain
|
| gptkbp:amendedBy |
engineered to consume phenylalanine
|
| gptkbp:clinicalTrialPhase |
Phase 2
|
| gptkbp:developedBy |
gptkb:Synlogic,_Inc.
|
| https://www.w3.org/2000/01/rdf-schema#label |
SYNB1618
|
| gptkbp:intendedUse |
treatment of phenylketonuria (PKU)
|
| gptkbp:mechanismOfAction |
degrades phenylalanine in the gastrointestinal tract
|
| gptkbp:organism |
gptkb:Escherichia_coli_Nissle_1917
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:status |
investigational
|
| gptkbp:target |
gptkb:phenylketonuria
|
| gptkbp:bfsParent |
gptkb:Synthetic_Biotic_medicines
|
| gptkbp:bfsLayer |
7
|